HeartSciences (HSCS) Finished Goods (2022 - 2026)
HeartSciences (HSCS) posted quarterly Finished Goods of $22581.0 for Q2 2026, down 48.76% year-on-year from $44069.0 in Q2 2025, and up 1.62% on a QoQ basis from $22221.0 in Q4 2025.
HeartSciences (HSCS) Finished Goods (2022 - 2026) Analysis & Trends
HeartSciences (HSCS) has reported Finished Goods for 5 consecutive years, with $22581.0 the latest figure, recorded in Q2 2026.
- Quarterly Finished Goods fell 48.76% year-over-year to $22581.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $22581.0 (down 48.76% YoY) and the FY2026 annual result came in at $22581.0, down 48.76% from the prior year.
- Finished Goods advanced to $22581.0 in Q2 2026 per HSCS's latest filing, from $22221.0 in the prior quarter.
- Over the last five years, Finished Goods for HSCS reached as high as $44069.0 in Q2 2025 and fell as low as $22221.0 in Q4 2025.
- A 5-year average of $28285.2 and a median of $28662.0 in 2022 frame the typical range for Finished Goods.
- Annual changes were most pronounced in 2025 — Finished Goods jumped 95.16% — and 2026, when it sank 48.76%.
- Year by year, Finished Goods stood at $28663.0 in 2022, then fell by 0.0% to $28662.0 in 2023, then slipped by 21.22% to $22581.0 in 2024, then declined by 1.59% to $22221.0 in 2025, then increased by 1.62% to $22581.0 in 2026.
- According to Business Quant data, Finished Goods over the past three periods registered $22581.0, $22221.0, and $44069.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | HeartSciences | 2.29 Mn | -1.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 22,581.00 |
| Oct 31, 2025 | 22,221.00 |
| Jul 31, 2025 | 44,069.00 |
| Apr 30, 2025 | 44,069.00 |
| Jan 31, 2025 | 22,581.00 |
| Oct 31, 2024 | 22,581.00 |
| Jul 31, 2024 | 22,581.00 |
| Apr 30, 2024 | 22,581.00 |
| Jan 31, 2024 | 28,662.00 |
| Oct 31, 2023 | 28,662.00 |
| Jul 31, 2023 | 28,662.00 |
| Apr 30, 2023 | 28,662.00 |
| Jan 31, 2023 | 28,663.00 |
| Oct 31, 2022 | 28,663.00 |
| Jul 31, 2022 | 28,663.00 |
| Apr 30, 2022 | 28,662.00 |